MyFinsight
Home
Blog
About
Contact
ctxr: the income statement
Download
Download image
Net loss applicable
to common...
-$37,433,911
(6.85%↑ Y/Y)
Net loss
attributable to...
-$2,306,358
(-703.61%↓ Y/Y)
Net loss
-$39,740,269
(-0.80%↓ Y/Y)
Income tax expense
$1,056,960
(83.50%↑ Y/Y)
Loss before income
taxes
-$38,683,309
(0.43%↑ Y/Y)
Total other income
(expense), net
-$157,701
(-105.01%↓ Y/Y)
Operating loss
-$38,525,608
(8.26%↑ Y/Y)
Interest income
$110,081
(-85.48%↓ Y/Y)
Interest expense
$267,782
Total operating
expenses
$38,525,608
(-8.26%↓ Y/Y)
Stock-based compensation
general and...
$10,836,291
(-8.47%↓ Y/Y)
General and
administrative
$18,532,843
(1.55%↑ Y/Y)
Research and development
$9,156,474
(-23.10%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Citius Pharmaceuticals, Inc. (CTXR)
Citius Pharmaceuticals, Inc. (CTXR)